Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 301, pseudogene (RN7SL301P)

Target
RN7SL301P
Molecular classification
Pseudogene, Non-coding RNA, Other
01

Overview

RN7SL301P is one of several hundred 7SL RNA-derived pseudogenes within the human genome. It is a truncated, non-functional genomic copy of the 7SL RNA gene, which normally encodes the RNA component of the signal recognition particle (SRP), an essential RNP complex for co-translational protein targeting to the endoplasmic reticulum[1][2][10]. Pseudogenes such as RN7SL301P do not encode protein and are typically not transcribed into functional RNA. However, in some cases, pseudogene transcripts may exert regulatory effects (for example, by acting as miRNA decoys or being processed into small interfering RNAs), but there is no evidence for a specific biological function, disease association, or therapeutic targeting of RN7SL301P itself[5][8][10]. Its closely related parent, RN7SL1 (7SL RNA), plays a well-understood structural and regulatory role, but pseudogenes such as RN7SL301P are generally considered genomic fossils or, at most, non-coding RNA regulators, and are not recognized as therapeutic targets. Key clarifications: - RN7SL301P is a pseudogene, not a gene encoding a functional protein, receptor, or enzyme and is not a therapeutic target[1][2][10]. - No approved drugs, biomarkers, or disease roles are directly assigned to this specific pseudogene[1][2]. - The entry is likely not a valid molecular target; if a therapeutic target related to 7SL RNA or the SRP is intended, RN7SL1 or components of the SRP complex should be searched instead[4][9].

Other names
RN7SL301P7SL RNA pseudogene 301
02

Biological functions

Can act as a non-coding RNA with potential regulatory roles such as miRNA decoy or siRNA precursor, but lacks canonical protein-coding or receptor/enzyme function
03

Disease associations

Other (Pseudogenes as a group may have regulatory or disease-modifying roles, but no specific direct disease association is established for RN7SL301P)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 301, pseudogene (RN7SL301P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 301, pseudogene (RN7SL301P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call